STANLEY BLACK & DECKER, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that STANLEY BLACK & DECKER, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $15.13B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $15.37B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $15.78B | Feb 24, 2026 |
| FY2022 | Dec 31, 2022 | $3.99B | Feb 23, 2023 |
| FY2022 | Oct 1, 2022 | $4.12B | Feb 23, 2023 |
| FY2022 | Jul 2, 2022 | $4.39B | Feb 23, 2023 |
| FY2022 | Apr 2, 2022 | $4.45B | Feb 23, 2023 |
| FY2022 | Jan 1, 2022 | $3.98B | Feb 23, 2023 |
| FY2022 | Oct 2, 2021 | $3.78B | Feb 23, 2023 |
| FY2022 | Jul 3, 2021 | $3.80B | Feb 23, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $3.41B | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $3.30B | Feb 27, 2018 |
| FY2017 | Jul 1, 2017 | $3.23B | Feb 27, 2018 |
| FY2017 | Apr 1, 2017 | $2.81B | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $2.92B | Feb 27, 2018 |
| FY2017 | Oct 1, 2016 | $2.88B | Feb 27, 2018 |
| FY2017 | Jul 2, 2016 | $2.93B | Feb 27, 2018 |
| FY2017 | Apr 2, 2016 | $2.67B | Feb 27, 2018 |
| FY2016 | Jan 2, 2016 | $2.92B | Feb 15, 2017 |
| FY2016 | Oct 3, 2015 | $2.88B | Feb 15, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $753.50M | Feb 23, 2023 |
| FY2022 | Oct 1, 2022 | $1.02B | Feb 23, 2023 |
| FY2022 | Jul 2, 2022 | $1.21B | Feb 23, 2023 |
| FY2022 | Apr 2, 2022 | $1.31B | Feb 23, 2023 |
| FY2022 | Jan 1, 2022 | $1.13B | Feb 23, 2023 |
| FY2022 | Oct 2, 2021 | $1.22B | Feb 23, 2023 |
| FY2022 | Jul 3, 2021 | $1.36B | Feb 23, 2023 |
| FY2022 | Apr 3, 2021 | $1.39B | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $1.40B | Feb 22, 2022 |
| FY2021 | Sep 26, 2020 | $1.23B | Feb 22, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $401.90M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $294.30M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | ($310.50M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.06B | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $1.69B | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $1.23B | Feb 23, 2023 |
| FY2019 | Dec 28, 2019 | $199.10M | Feb 21, 2020 |
| FY2017 | Dec 29, 2018 | ($106.80M) | Feb 26, 2019 |
| FY2019 | Sep 29, 2018 | $230.50M | Feb 21, 2020 |
| FY2019 | Jun 30, 2018 | $356.30M | Feb 21, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 2, 2021 | $2.18B | Jan 31, 2022 |
| FY2020 | Dec 28, 2019 | $1.99B | Jan 31, 2022 |
| FY2020 | Dec 29, 2018 | $1.88B | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $2.00B | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $1.83B | Feb 26, 2019 |
| FY2017 | Jan 2, 2016 | $1.75B | Feb 27, 2018 |
| FY2016 | Jan 3, 2015 | $1.68B | Feb 15, 2017 |
| FY2015 | Dec 28, 2013 | $1.47B | Feb 19, 2016 |
| FY2014 | Dec 29, 2012 | $1.44B | Feb 19, 2015 |
| FY2013 | Dec 31, 2011 | $1.34B | Feb 21, 2014 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $321.40M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $328.80M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $362.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $357.40M | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $276.30M | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $200.00M | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $240.80M | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $275.80M | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $252.30M | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $204.40M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $3.31B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $3.31B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $3.28B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.36B | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $3.19B | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $2.55B | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $2.54B | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $3.14B | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $2.98B | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $2.61B | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $971.20M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $1.11B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $1.19B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($1.46B) | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $663.10M | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $2.02B | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $1.51B | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $1.26B | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $668.50M | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $1.19B | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $283.30M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $353.90M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $338.70M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $530.40M | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $519.10M | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $348.10M | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $424.70M | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $492.10M | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $442.40M | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $347.00M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $21.24B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $21.85B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $23.66B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $24.96B | Feb 27, 2024 |
| FY2022 | Jan 1, 2022 | $28.18B | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $23.57B | Feb 22, 2022 |
| FY2020 | Dec 28, 2019 | $20.60B | Jan 31, 2022 |
| FY2020 | Dec 29, 2018 | $19.41B | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $19.10B | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $15.66B | Feb 26, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $9.05B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $8.72B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $9.06B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $9.71B | Feb 27, 2024 |
| FY2022 | Jan 1, 2022 | $11.59B | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $11.06B | Feb 22, 2022 |
| FY2020 | Dec 28, 2019 | $9.14B | Jan 31, 2022 |
| FY2019 | Dec 29, 2018 | $7.84B | Feb 21, 2020 |
| FY2017 | Dec 30, 2017 | $8.30B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $6.37B | Feb 27, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $7.29B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $7.91B | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $8.00B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $8.50B | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $8.59B | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $7.89B | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $7.38B | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $8.96B | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $8.78B | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $6.69B | Feb 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $8.24B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $8.34B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $8.54B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $9.33B | Feb 27, 2024 |
| FY2022 | Jan 1, 2022 | $8.74B | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $7.54B | Feb 22, 2022 |
| FY2020 | Dec 28, 2019 | $6.77B | Jan 31, 2022 |
| FY2020 | Dec 29, 2018 | $6.22B | Jan 31, 2022 |
| FY2020 | Dec 30, 2017 | $6.00B | Jan 31, 2022 |
| FY2017 | Dec 31, 2016 | $5.13B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $280.10M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $290.50M | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $449.40M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $395.60M | Feb 27, 2024 |
| FY2022 | Jan 1, 2022 | $142.10M | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $1.24B | Feb 22, 2022 |
| FY2020 | Dec 28, 2019 | $297.70M | Jan 31, 2022 |
| FY2019 | Dec 29, 2018 | $288.70M | Feb 21, 2020 |
| FY2017 | Dec 30, 2017 | $637.50M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.13B | Feb 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $5.26B | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $6.10B | Feb 24, 2026 |
| FY2024 | Dec 30, 2023 | $6.10B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $5.35B | Feb 27, 2024 |
| FY2022 | Jan 1, 2022 | $4.35B | Feb 23, 2023 |
| FY2021 | Jan 2, 2021 | $4.25B | Feb 22, 2022 |
| FY2020 | Dec 28, 2019 | $3.18B | Jan 31, 2022 |
| FY2015 | Jan 2, 2016 | $3.84B | Feb 19, 2016 |
| FY2015 | Jan 3, 2015 | $3.85B | Feb 19, 2016 |
| FY2014 | Dec 28, 2013 | $3.81B | Feb 19, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 2 | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | (2) | Feb 24, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Feb 23, 2023 |
| FY2022 | Oct 1, 2022 | 5 | Feb 23, 2023 |
| FY2022 | Jul 2, 2022 | 0 | Feb 23, 2023 |
| FY2022 | Apr 2, 2022 | 1 | Feb 23, 2023 |
| FY2022 | Jan 1, 2022 | 2 | Feb 23, 2023 |
| FY2022 | Oct 2, 2021 | 2 | Feb 23, 2023 |
| FY2022 | Jul 3, 2021 | 2 | Feb 23, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 2 | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 1 | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | (2) | Feb 24, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Feb 23, 2023 |
| FY2022 | Oct 1, 2022 | 5 | Feb 23, 2023 |
| FY2022 | Jul 2, 2022 | 0 | Feb 23, 2023 |
| FY2022 | Apr 2, 2022 | 1 | Feb 23, 2023 |
| FY2022 | Jan 1, 2022 | 1 | Feb 23, 2023 |
| FY2022 | Oct 2, 2021 | 2 | Feb 23, 2023 |
| FY2022 | Jul 3, 2021 | 2 | Feb 23, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 155.04M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | 154.37M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | 153.62M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | 152.98M | Feb 24, 2026 |
| FY2024 | Jan 1, 2022 | 163.33M | Feb 18, 2025 |
| FY2023 | Jan 2, 2021 | 160.75M | Feb 27, 2024 |
| FY2022 | Dec 28, 2019 | 153.51M | Feb 23, 2023 |
| FY2021 | Dec 29, 2018 | 151.30M | Feb 22, 2022 |
| FY2020 | Dec 30, 2017 | 154.04M | Jan 31, 2022 |
| FY2017 | Dec 31, 2016 | 152.56M | Feb 26, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $500.60M | Feb 24, 2026 |
| FY2025 | Dec 28, 2024 | $491.20M | Feb 24, 2026 |
| FY2025 | Dec 30, 2023 | $482.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $465.80M | Feb 18, 2025 |
| FY2023 | Jan 1, 2022 | $474.80M | Feb 27, 2024 |
| FY2022 | Jan 2, 2021 | $431.80M | Feb 23, 2023 |
| FY2021 | Dec 28, 2019 | $402.00M | Feb 22, 2022 |
| FY2020 | Dec 29, 2018 | $384.90M | Jan 31, 2022 |
| FY2019 | Dec 30, 2017 | $362.90M | Feb 21, 2020 |
| FY2017 | Dec 31, 2016 | $330.90M | Feb 26, 2019 |